« Return to News | CROs/Service Providers

AmerisourceBergen to acquire World Courier

Thursday, March 8, 2012 12:31 PM

AmerisourceBergen has agreed to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

Stamford, Conn.-based World Courier, which provides transportation, storage and distribution services for multinational biopharmaceutical clinical trials in addition to other end markets, will become a new operating segment within AmerisourceBergen.

“The acquisition of World Courier adds a new premium specialty service to our existing portfolio of market-leading pharmaceutical manufacturer services,” said Steven H. Collis, AmerisourceBergen president and CEO.

World Courier’s president, Wayne B. Heyland, will continue in his position, reporting directly to Collis. “We are very pleased to bring our decades of experience serving international biopharmaceutical manufacturers and CROs to AmerisourceBergen,” said Heyland.

AmerisourceBergen services healthcare providers and pharmaceutical manufacturers, providing drug distribution and related services to reduce costs and improve patient outcomes. Its services range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. Headquartered in Valley Forge, Penn., it has $80 billion in annual revenue and approximately 11,000 employees.

World Courier’s annual revenues are expected to be approximately $500 million in calendar year 2012. It has over 137 offices, 13 GMP-compliant storage depots and 2,500 employees in 52 countries.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.